Evidence map›Paper›PMID 37915914›Full record

ArticleClinical kidney journal2023

Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease-prospective data from the German Chronic Kidney Disease cohort.

Johannes Ruhe, Jennifer Nadal, Barbara Bärthlein, Heike Meiselbach, Ulla T Schultheiss, Fruzsina Kotsis, Helena Stockmann, Vera Krane, Claudia Sommerer, Ivonne Löffler and 9 more

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Johannes RuheDepartment of Internal Medicine III, Nephrology, University Hospital Jena - Friedrich Schiller University, Jena, Germany.
Jennifer NadalDepartment of Medical Biometry, Informatics, and Epidemiology, University Hospital Bonn, Bonn, Germany.
Barbara BärthleinMedical Centre for Information and Communication Technology, University Hospital Erlangen, Erlangen, Germany.
Heike MeiselbachDepartment of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Ulla T SchultheissInstitute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Fruzsina KotsisInstitute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Helena StockmannDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Vera KraneDivision of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
Claudia SommererNephrology Unit, University Hospital Heidelberg, Heidelberg, Germany.
Ivonne LöfflerDepartment of Internal Medicine III, Nephrology, University Hospital Jena - Friedrich Schiller University, Jena, Germany.
Turgay SaritasDivision of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
Jan T KielsteinMedical Clinic V Nephrology, Rheumatology, Blood Purification - Academic Teaching Hospital Braunschweig, Braunschweig, Germany.
Thomas SitterDepartment of Medicine, Ludwig-Maximilians-University Hospital Munich, Munich, Germany.
Markus P SchneiderDepartment of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Matthias SchmidDepartment of Medical Biometry, Informatics, and Epidemiology, University Hospital Bonn, Bonn, Germany.
Christoph WannerDivision of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
Kai-Uwe EckardtDepartment of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Gunter WolfDepartment of Internal Medicine III, Nephrology, University Hospital Jena - Friedrich Schiller University, Jena, Germany.
Martin BuschDepartment of Internal Medicine III, Nephrology, University Hospital Jena - Friedrich Schiller University, Jena, Germany.ORCID https://orcid.org/0000-0002-7889-6156
Friedrich Schiller University Jena · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Würzburg · DEUniversity Hospital Bonn · DEUniversity of Freiburg · DECharité - Universitätsmedizin Berlin · DEHeidelberg University · DEKlinikum Braunschweig · DELudwig-Maximilians-Universität München · DERWTH Aachen University · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus (DM) and chronic kidney disease (CKD) are well-known cardiovascular and mortality risk factors. To what extent they act in an additive manner and whether the etiology of CKD modifies the risk is uncertain. Methods: The multicenter, prospective, observational German Chronic Kidney Disease study comprises 5217 participants (1868 with DM) with a baseline mean estimated glomerular filtration rate of 30-60 mL/min/1.73 m Results: During the 6.5-year follow-up 603 (12%) non-cardiovascular and 209 (4%) cardiovascular deaths, 645 (12%) 4-point MACE, and 398 (8%) HHF were observed, most frequently in patients with DM having CKDcvm. DM increased the risk of non-cardiovascular [hazard ratio (HR) 1.92; 95% confidence interval (CI) 1.59-2.32] and cardiovascular (HR 2.25; 95% CI 1.62-3.12) deaths, 4-point MACE (HR 1.93; 95% CI 1.62-2.31) and HHF (HR 1.87; 95% CI 1.48-2.36). Mortality risks were elevated by DM to a similar extent in CKDcvm and CKDgen, but for HHF in CKDcvm only (HR 2.07; 95% CI 1.55-2.77). In patients with DM, CKDcvm (versus CKDgen) only increased the risk for HHF (HR 1.93; 95% CI 1.15-3.22). Conclusions: DM contributes to cardiovascular and mortality excess risk in patients with moderate to severe CKD in both, CKDcvm and CKDgen. Patients with DM and CKDcvm are particularly susceptible to HHF.

Indexed as

cardiometabolic kidney diseasecardiovascular riskchronic kidney diseasediabetes mellitusdiabetic kidney disease

Identifiers

PMID37915914
PMCPMC10616496
OpenAlexW4386348820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.